Advisory Board on Radiation and Worker Health (ABRWH or Advisory Board), National Institute for Occupational Safety and Health (NIOSH); Meeting, 43090-43091 [2012-17880]
Download as PDF
<![CDATA[
43090
Federal Register / Vol. 77, No. 141 / Monday, July 23, 2012 / Notices
vitae, and a brief summary of relevant
experience and qualifications.
mstockstill on DSK4VPTVN1PROD with NOTICES
Request for Data
NICEATM invites the submission of
data for substances tested in
standardized in vivo acute dermal
systemic toxicity tests. Corresponding
acute oral LD50 data for the same
compounds tested dermally would be
particularly useful. Oral data from rat
tests and dermal data from rat and/or
rabbit tests are preferred. Although data
can be accepted at any time, please
submit data by September 6, 2012 to
ensure consideration during the
ICCVAM evaluation process. Relevant
data received after this date will be
considered where feasible. All
information submitted in response to
this notice will be made publicly
available and may be incorporated into
future NICEATM and ICCVAM reports
and publications, as appropriate.
When submitting data, please
reference this Federal Register notice
and provide appropriate contact
information (name, affiliation, mailing
address, phone, fax, email, and
sponsoring organization, as applicable).
NICEATM prefers that data be
submitted electronically as copies of
pages from study notebooks,
spreadsheets, and/or study reports. Each
submission for a substance should
preferably include the following
information, as appropriate: common
and trade name, Chemical Abstracts
Service Registry Number (CASRN),
commercial source, in vivo test
protocols used, extent to which the data
were collected in accordance with
national or international Good
Laboratory Practice guidelines, date and
testing organization, physical and
chemical properties (e.g., molecular
weight, pH, water solubility, log Kow,
etc.), estimated LD50, and incidence of
death and other adverse effects.
Background Information on ICCVAM
and NICEATM
ICCVAM is an interagency committee
composed of representatives from 15
Federal regulatory and research agencies
that require, use, generate, or
disseminate toxicological and safety
testing information. ICCVAM conducts
technical evaluations of new, revised,
and alternative safety testing methods
and integrated testing strategies with
regulatory applicability and promotes
the scientific validation and regulatory
acceptance of testing methods that more
accurately assess the safety and hazards
of chemicals and products and that
reduce, refine (enhance animal wellbeing and lessen or avoid pain and
distress), or replace animal use. The
VerDate Mar<15>2010
19:21 Jul 20, 2012
Jkt 226001
ICCVAM Authorization Act of 2000 (42
U.S.C. 285l–3) established ICCVAM as a
permanent interagency committee of the
NIEHS under NICEATM. NICEATM
administers ICCVAM, provides
scientific and operational support for
ICCVAM-related activities, and
conducts independent validation
studies to assess the usefulness and
limitations of new, revised, and
alternative test methods and strategies.
NICEATM and ICCVAM welcome the
public nomination of new, revised, and
alternative test methods and strategies
for validation studies and technical
evaluations. Additional information
about NICEATM and ICCVAM can be
found on the NICEATM–ICCVAM Web
site (https://iccvam.niehs.nih.gov).
References
Bronstein AC, Spyker DA, Cantilena LR, Jr,
Green JL, Rumack BH, Giffin SL. 2010.
2009 Annual Report of the American
Association of Poison Control Centers’
National Poison Data System (NPDS):
27th Annual Report. Clinical Toxicology
48: 979–1178.
EPA. 1998. Health Effects Test Guidelines:
OPPTS 870.1200—Acute Dermal
Toxicity. EPA 712–C–98–192.
Washington, DC:U.S. Environmental
Protection Agency. Available: https://
www.epa.gov/ocspp/pubs/frs/
publications/Test_Guidelines/
series870.htm.
ICCVAM. 2008. NICEATM–ICCVAM FiveYear Plan (2008–2012): A Plan to
Advance Alternative Test Methods of
High Scientific Quality to Protect and
Advance the Health of People, Animals
and the Environment. Research Triangle
Park, NC: National Institute of
Environmental Health Sciences.
Available: https://iccvam.niehs.nih.gov/
docs/5yearplan.htm.
OECD. 1987. Test No. 402. Acute Dermal
Toxicity [adopted 24 February 1987]. In:
OECD Guidelines for the Testing of
Chemicals, Section 4: Health Effects.
Paris:OECD Publishing. Available: https://
dx.doi.org/10.1787/9789264070585-en.
OECD. 2001. Test No. 425. Acute Oral
Toxicity—Up-and-Down Procedure
[adopted 17 December 2001]. In: OECD
Guidelines for the Testing of Chemicals,
Section 4: Health Effects. Paris:OECD
Publishing. Available: www.oecd.org/
dataoecd/17/51/1948378.pdf.
Dated: July 12, 2012.
John R. Bucher,
Associate Director, National Toxicology
Program.
[FR Doc. 2012–17787 Filed 7–20–12; 8:45 am]
BILLING CODE 4140–01–P
PO 00000
Frm 00046
Fmt 4703
Sfmt 4703
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Safety and Occupational Health Study
Section: Notice of Charter Renewal
This gives notice under the Federal
Advisory Committee Act (Pub. L. 92–
463) of October 6, 1972, that the Safety
and Occupational Health Study Section,
Centers for Disease Control and
Prevention, Department of Health and
Human Services, has been renewed for
a 2-year period through June 30, 2014.
For more information contact: Price
Connor, Ph.D., Executive Secretary,
Safety and Occupational Health Study
Section, Department of Health and
Human Services, 1600 Clifton Road NE.,
Mailstop E74, Atlanta, Georgia 30333,
telephone 404/498–2511 or fax 404/
498–2571.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities, for both the
Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Dated: July 16, 2012.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. 2012–17879 Filed 7–20–12; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Advisory Board on Radiation and
Worker Health (ABRWH or Advisory
Board), National Institute for
Occupational Safety and Health
(NIOSH); Meeting
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces the following meeting of the
aforementioned committee:
TIME AND DATE: 11:00 a.m.–3:00 p.m.,
August 15, 2012.
PLACE: Audio Conference Call via FTS
Conferencing. The USA toll-free, dial-in
number is 1–866–659–0537 and the pass
code is 9933701.
STATUS: Open to the public, but without
a verbal public comment period.
E:\FR\FM\23JYN1.SGM
23JYN1
43091
Federal Register / Vol. 77, No. 141 / Monday, July 23, 2012 / Notices
Written comments should be provided
to the contact person below in advance
of the meeting.
Background: The Advisory Board was
established under the Energy Employees
Occupational Illness Compensation
Program Act of 2000 to advise the
President on a variety of policy and
technical functions required to
implement and effectively manage the
new compensation program. Key
functions of the Advisory Board include
providing advice on the development of
probability of causation guidelines,
which have been promulgated by the
Department of Health and Human
Services (HHS) as a final rule; advice on
methods of dose reconstruction, which
have also been promulgated by HHS as
a final rule; advice on the scientific
validity and quality of dose estimation
and reconstruction efforts being
performed for purposes of the
compensation program; and advice on
petitions to add classes of workers to the
Special Exposure Cohort (SEC).
In December 2000, the President
delegated responsibility for funding,
staffing, and operating the Advisory
Board to HHS, which subsequently
delegated this authority to the CDC.
NIOSH implements this responsibility
for CDC. The charter was issued on
August 3, 2001, renewed at appropriate
intervals, most recently, August 3, 2011,
and will expire on August 3, 2013.
Purpose: This Advisory Board is
charged with (a) providing advice to the
Secretary, HHS, on the development of
guidelines under Executive Order
13179; (b) providing advice to the
Secretary, HHS, on the scientific
validity and quality of dose
reconstruction efforts performed for this
program; and (c) upon request by the
Secretary, HHS, advising the Secretary
on whether there is a class of employees
at any Department of Energy facility
who were exposed to radiation but for
whom it is not feasible to estimate their
radiation dose, and on whether there is
reasonable likelihood that such
radiation doses may have endangered
the health of members of this class.
Matters to be Discussed: The agenda
for the conference call includes: SEC
Petition for Ventron Corporation
(Beverly, Massachusetts); Dose
Reconstruction Review Subcommittee
Update; Subcommittee and Work Group
Updates; SEC Petition Evaluations
Update for the September 2012
Advisory Board Meeting; Plans for
September 2012 Advisory Board
Meeting; and Advisory Board
Correspondence.
The agenda is subject to change as
priorities dictate.
Because there is not a verbal public
comment period, written comments may
be submitted. Any written comments
received will be included in the official
record of the meeting and should be
submitted to the contact person below
in advance of the meeting.
CONTACT PERSON FOR MORE INFORMATION:
Theodore M. Katz, M.P.A., Designated
Federal Officer, NIOSH, CDC, 1600
Clifton Road NE., Mailstop E–20,
Atlanta, Georgia 30333, Telephone (513)
533–6800, Toll Free 1–800–CDC–INFO;
Email ocas@cdc.gov.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
Notices pertaining to announcements of
meetings and other committee
management activities, for both the
Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Dated: July 16, 2012.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. 2012–17880 Filed 7–20–12; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Administration for Children and
Families
Proposed Information Collection
Activity; Comment Request
Title: Data Collection Plan for a
Follow-up Survey with Child Welfare
Information Gateway Customers.
OMB No.: New Collection.
Description: The proposed
information collection activity includes
a follow-up survey designed to assess
how professional customers are using
information received from Child
Welfare Information Gateway. Child
Welfare Information Gateway is a
service of the Children’s Bureau, a
component within the Administration
for Children and Families, and is
dedicated to the mission of connecting
professionals and concerned citizens to
information on programs, research,
legislation, and statistics regarding the
safety, permanency, and well-being of
children and families. The follow-up
survey will gather data about how
professionals use Child Welfare
Information Gateway’s information
services in their work. Survey findings
will be applied to make continuous
improvements to Child Welfare
Information Gateway’s Web site and
other information services.
Respondents: Child Welfare
Information Gateway professional users.
ANNUAL BURDEN ESTIMATES
Number of
respondents
Instrument
mstockstill on DSK4VPTVN1PROD with NOTICES
Private Sector—Follow-up Survey ...................................................................
State, Local or Tribal Goverments—Follow-up Survey ...................................
Estimated Total Annual Burden
Hours: 33.4 hours.
In compliance with the requirements
of Section 506(c)(2)(A) of the Paperwork
Reduction Act of 1995, the
Administration for Children and
Families is soliciting public comment
on the specific aspects of the
information collection described above.
Copies of the proposed collection of
information can be obtained and
VerDate Mar<15>2010
19:21 Jul 20, 2012
Jkt 226001
100
100
comments may be forwarded by writing
to the Administration for Children and
Families, Office of Planning, Research
and Evaluation, 370 L’Enfant
Promenade SW., Washington, DC 20447,
Attn: ACF Reports Clearance Officer.
Email address:
infocollection@acf.hhs.gov. All requests
should be identified by the title of the
information collection.
PO 00000
Frm 00047
Fmt 4703
Sfmt 4703
Number of
responses per
respondent
1
1
Average
burden hours
per response
0.167
0.167
Total burden
hours
16.7
16.7
The Department specifically requests
comments on: (a) Whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information shall have
practical utility; (b) the accuracy of the
agency’s estimate of the burden of the
proposed collection of information; (c)
the quality, utility, and clarity of the
E:\FR\FM\23JYN1.SGM
23JYN1
]]>Agencies
[Federal Register Volume 77, Number 141 (Monday, July 23, 2012)]
[Notices]
[Pages 43090-43091]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2012-17880]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Advisory Board on Radiation and Worker Health (ABRWH or Advisory
Board), National Institute for Occupational Safety and Health (NIOSH);
Meeting
In accordance with section 10(a)(2) of the Federal Advisory
Committee Act (Pub. L. 92-463), the Centers for Disease Control and
Prevention (CDC) announces the following meeting of the aforementioned
committee:
Time and Date: 11:00 a.m.-3:00 p.m., August 15, 2012.
Place: Audio Conference Call via FTS Conferencing. The USA toll-free,
dial-in number is 1-866-659-0537 and the pass code is 9933701.
Status: Open to the public, but without a verbal public comment period.
[[Page 43091]]
Written comments should be provided to the contact person below in
advance of the meeting.
Background: The Advisory Board was established under the Energy
Employees Occupational Illness Compensation Program Act of 2000 to
advise the President on a variety of policy and technical functions
required to implement and effectively manage the new compensation
program. Key functions of the Advisory Board include providing advice
on the development of probability of causation guidelines, which have
been promulgated by the Department of Health and Human Services (HHS)
as a final rule; advice on methods of dose reconstruction, which have
also been promulgated by HHS as a final rule; advice on the scientific
validity and quality of dose estimation and reconstruction efforts
being performed for purposes of the compensation program; and advice on
petitions to add classes of workers to the Special Exposure Cohort
(SEC).
In December 2000, the President delegated responsibility for
funding, staffing, and operating the Advisory Board to HHS, which
subsequently delegated this authority to the CDC. NIOSH implements this
responsibility for CDC. The charter was issued on August 3, 2001,
renewed at appropriate intervals, most recently, August 3, 2011, and
will expire on August 3, 2013.
Purpose: This Advisory Board is charged with (a) providing advice
to the Secretary, HHS, on the development of guidelines under Executive
Order 13179; (b) providing advice to the Secretary, HHS, on the
scientific validity and quality of dose reconstruction efforts
performed for this program; and (c) upon request by the Secretary, HHS,
advising the Secretary on whether there is a class of employees at any
Department of Energy facility who were exposed to radiation but for
whom it is not feasible to estimate their radiation dose, and on
whether there is reasonable likelihood that such radiation doses may
have endangered the health of members of this class.
Matters to be Discussed: The agenda for the conference call
includes: SEC Petition for Ventron Corporation (Beverly,
Massachusetts); Dose Reconstruction Review Subcommittee Update;
Subcommittee and Work Group Updates; SEC Petition Evaluations Update
for the September 2012 Advisory Board Meeting; Plans for September 2012
Advisory Board Meeting; and Advisory Board Correspondence.
The agenda is subject to change as priorities dictate.
Because there is not a verbal public comment period, written
comments may be submitted. Any written comments received will be
included in the official record of the meeting and should be submitted
to the contact person below in advance of the meeting.
CONTACT Person for More Information: Theodore M. Katz, M.P.A.,
Designated Federal Officer, NIOSH, CDC, 1600 Clifton Road NE., Mailstop
E-20, Atlanta, Georgia 30333, Telephone (513) 533-6800, Toll Free 1-
800-CDC-INFO; Email ocas@cdc.gov.
The Director, Management Analysis and Services Office, has been
delegated the authority to sign Federal Register Notices pertaining to
announcements of meetings and other committee management activities,
for both the Centers for Disease Control and Prevention and the Agency
for Toxic Substances and Disease Registry.
Dated: July 16, 2012.
Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease
Control and Prevention.
[FR Doc. 2012-17880 Filed 7-20-12; 8:45 am]
BILLING CODE 4163-18-P
